Pharmacology of Antihistamines

Risk of first-generation H1-antihistamines: a GA2LEN position paper

(2010) M. K. Church et al.   ALLERGY

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria

(2010) Maria Staevska et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The concept of receptor occupancy to predict clinical efficacy: A comparison of second generation H1 antihistamines

(2009) Sherwin Gillman et al.   ALLERGY AND ASTHMA PROCEEDINGS

A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis

(2009) Claus Bachert   CLINICAL THERAPEUTICS

Clinical pharmacokinetics of fexofenadine enantiomers

(2009) Masatomo Miura et al.   Expert Opinion on Drug Metabolism & Toxicology

Dose dependency of brain histamine H1 receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin

(2009) Manabu Tashiro et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

H1 antihistamine drug promethazine directly blocks hERG K+ channel

(2009) Su-Hyun Jo et al.   PHARMACOLOGICAL RESEARCH

Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients

(2008) P. C. Potter et al.   ALLERGY

Non-Interventional Study Comparing Treatment Satisfaction in Patients Treated with Antihistamines

(2008) Christine De Vos et al.   CLINICAL DRUG INVESTIGATION

Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine

(2008) Philippe Devillier et al.   CLINICAL PHARMACOKINETICS

Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study

(2008) Giorgio Walter Canonica et al.   CURRENT MEDICAL RESEARCH AND OPINION

The H1 histamine receptor blocker, chlorpheniramine, completely prevents the increase in REM sleep induced by immobilization stress in rats

(2008) J.A. Rojas-Zamorano et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656

(2007) Sang-Joon Park et al.   JOURNAL OF APPLIED TOXICOLOGY